The goal of Insights in IPF is to provide healthcare professionals with a website containing peer-reviewed educational materials and tools to provide an understanding about idiopathic pulmonary fibrosis (IPF) and to aid in evaluating, diagnosing, and managing patients with IPF. Healthcare professionals can find frequently updated content and resources, including perspectives from experts in the field, as well as links to relevant publications, congress information, and other IPF news.
Registration Signup
Sign up to receive the latest news and learn about new developments related to IPF.
Use the GAP calculator to predict your patient’s mortality risk based on their Gender, Age, and Physiology (FVC and DLCO). This calculator is intended to inform prognosis and guide patient management decisions using readily-available clinical measures.
Click here for more information
Browse top-line reviews of recently-published, newsworthy articles relevant to the IPF community, with a focus on those with potential implications for patient care. Find out more
Here you can find information of interest for radiologists, or brush up on the radiologic features of interstitial lung disease! Find out more
In this section, view short videos featuring experts in the IPF field. New videos will be added and featured as they become available. Find out more
Access frequently updated educational and informative resources to help you identify and talk to your patients about IPF. Find out more
Over the past decade, much progress has been made in understanding the natural history of IPF and risk factors associated with the disease. Importantly, research into the pathogenesis of IPF is yielding new insights. Find out more
Because of the functional impact and poor prognosis, it is important to make an early and accurate diagnosis of IPF to allow for appropriate and optimal management of symptoms and quality-of-life issues in patients with this disease. Find out more
Clinical monitoring of your patients with IPF supports effective management. It is recommended to follow-up at 3- to 6-month periods with assessments focusing on physiologic and/or symptomatic changes that portend a poor outcome. Find out more
Naftali Kaminski, MD
New Haven, CT
Lisa Lancaster, MD
Vanderbilt University
Eric White, MD
University of Michigan
Open Navigation Panel